APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hidradenitis Suppurativa Treatment

Hidradenitis suppurativa (HS) is a painful, long-term skin condition that causes abscesses and scarring on the skin.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Hidradenitis suppurativa (HS) is a painful, long-term skin condition that causes abscesses and scarring on the skin.

The exact cause of hidradenitis suppurativa is unknown, but it occurs near hair follicles where there are sweat glands, usually around the groin, bottom, breasts and armpits.

There's no cure for HS, but treatments and lifestyle changes can bring some relief and cut down on flare-ups.

Selected research

Market Structure

Global Hidradenitis Suppurativa Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025194 pages

Choose your research edition.

Industry ResearchHidradenitis Suppurativa Treatment Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Hidradenitis Suppurativa Treatment Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Hidradenitis Suppurativa Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hidradenitis Suppurativa Treatment Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Hidradenitis Suppurativa Treatment Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

Hidradenitis suppurativa (HS) is a painful, long-term skin condition that causes abscesses and scarring on the skin.

The exact cause of hidradenitis suppurativa is unknown, but it occurs near hair follicles where there are sweat glands, usually around the groin, bottom, breasts and armpits.

There's no cure for HS, but treatments and lifestyle changes can bring some relief and cut down on flare-ups.

Read the full market overview

The classification of Hidradenitis Suppurativa Treatment includes Medications, Surgery and others, and the proportion of Medications in 2019 is about 76%.

Hidradenitis Suppurativa Treatment is widely used in Hospital, Clinical and other field. The most proportion of Hidradenitis Suppurativa Treatment is Hospital, and the proportion in 2019 is 53.53%.

Europe is the largest consumption place with a consumption market share of 47.76% in 2019. Following Europe, Asia Pacific is the second largest consumption place with the consumption market share of 23.97%.

Market competition is intense. AbbVie, Merck, Pfizer, AstraZeneca, GlaxoSmithKline, etc. are the leaders of the industry.

Report Includes

This report provides an overview of the global Hidradenitis Suppurativa Treatment market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Hidradenitis Suppurativa Treatment and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hidradenitis Suppurativa Treatment revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Hidradenitis Suppurativa Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

Hidradenitis Suppurativa Treatment Segment by Company

AbbVie

Merck

Pfizer

AstraZeneca

GlaxoSmithKline

Perrigo

Sun Pharma

Almirall

Bausch Health

Johnson & Johnson

Hidradenitis Suppurativa Treatment Segment by Type

Medications

Surgery

Others

Hidradenitis Suppurativa Treatment Segment by Application

Hospitals

Clinics

Others

Hidradenitis Suppurativa Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hidradenitis Suppurativa Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hidradenitis Suppurativa Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hidradenitis Suppurativa Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Hidradenitis Suppurativa Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Hidradenitis Suppurativa Treatment industry.

Chapter 3: Detailed analysis of Hidradenitis Suppurativa Treatment companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hidradenitis Suppurativa Treatmentrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Hidradenitis Suppurativa Treatment Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Medications Table 3. Key Players of Surgery Table 4. Key Players of Others Table 4. Global Hidradenitis Suppurativa Treatment Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospitals Table 6. Key Players of Clinics Table 7. Key Players of Others Table 8. Global Hidradenitis Suppurativa Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Hidradenitis Suppurativa Treatment Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Hidradenitis Suppurativa Treatment Market Share by Region (2021-2026) Table 11. Global Hidradenitis Suppurativa Treatment Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Hidradenitis Suppurativa Treatment Market Share by Region (2027-2032) Table 13. Hidradenitis Suppurativa Treatment Industry Trends Table 14. Hidradenitis Suppurativa Treatment Industry Drivers Table 15. Hidradenitis Suppurativa Treatment Industry Opportunities and Challenges Table 16. Hidradenitis Suppurativa Treatment Industry Restraints Table 17. Global Hidradenitis Suppurativa Treatment Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Hidradenitis Suppurativa Treatment Revenue Market Share by Company (2021-2026) Table 19. Global Hidradenitis Suppurativa Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Hidradenitis Suppurativa Treatment Key Company Head Office and Area Served Table 21. Global Hidradenitis Suppurativa Treatment Company, Product Type & Application Table 22. Global Hidradenitis Suppurativa Treatment Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Hidradenitis Suppurativa Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Hidradenitis Suppurativa Treatment Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Hidradenitis Suppurativa Treatment Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Hidradenitis Suppurativa Treatment Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Hidradenitis Suppurativa Treatment Revenue Market Share by Type (2021-2026) Table 29. Global Hidradenitis Suppurativa Treatment Revenue Market Share by Type (2027-2032) Table 30. Global Hidradenitis Suppurativa Treatment Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Hidradenitis Suppurativa Treatment Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Hidradenitis Suppurativa Treatment Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Hidradenitis Suppurativa Treatment Revenue Market Share by Application (2021-2026) Table 34. Global Hidradenitis Suppurativa Treatment Revenue Market Share by Application (2027-2032) Table 35. AbbVie Company Information Table 36. AbbVie Business Overview Table 37. AbbVie Hidradenitis Suppurativa Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. AbbVie Hidradenitis Suppurativa Treatment Product Portfolio Table 39. AbbVie Recent Development Table 40. Merck Company Information Table 41. Merck Business Overview Table 42. Merck Hidradenitis Suppurativa Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Merck Hidradenitis Suppurativa Treatment Product Portfolio Table 44. Merck Recent Development Table 45. Pfizer Company Information Table 46. Pfizer Business Overview Table 47. Pfizer Hidradenitis Suppurativa Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Pfizer Hidradenitis Suppurativa Treatment Product Portfolio Table 49. Pfizer Recent Development Table 50. AstraZeneca Company Information Table 51. AstraZeneca Business Overview Table 52. AstraZeneca Hidradenitis Suppurativa Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. AstraZeneca Hidradenitis Suppurativa Treatment Product Portfolio Table 54. AstraZeneca Recent Development Table 55. GlaxoSmithKline Company Information Table 56. GlaxoSmithKline Business Overview Table 57. GlaxoSmithKline Hidradenitis Suppurativa Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. GlaxoSmithKline Hidradenitis Suppurativa Treatment Product Portfolio Table 59. GlaxoSmithKline Recent Development Table 60. Perrigo Company Information Table 61. Perrigo Business Overview Table 62. Perrigo Hidradenitis Suppurativa Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Perrigo Hidradenitis Suppurativa Treatment Product Portfolio Table 64. Perrigo Recent Development Table 65. Sun Pharma Company Information Table 66. Sun Pharma Business Overview Table 67. Sun Pharma Hidradenitis Suppurativa Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Sun Pharma Hidradenitis Suppurativa Treatment Product Portfolio Table 69. Sun Pharma Recent Development Table 70. Almirall Company Information Table 71. Almirall Business Overview Table 72. Almirall Hidradenitis Suppurativa Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Almirall Hidradenitis Suppurativa Treatment Product Portfolio Table 74. Almirall Recent Development Table 75. Bausch Health Company Information Table 76. Bausch Health Business Overview Table 77. Bausch Health Hidradenitis Suppurativa Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Bausch Health Hidradenitis Suppurativa Treatment Product Portfolio Table 79. Bausch Health Recent Development Table 80. Johnson & Johnson Company Information Table 81. Johnson & Johnson Business Overview Table 82. Johnson & Johnson Hidradenitis Suppurativa Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Johnson & Johnson Hidradenitis Suppurativa Treatment Product Portfolio Table 84. Johnson & Johnson Recent Development Table 85. North America Hidradenitis Suppurativa Treatment Market Size by Type (2021-2026) & (US$ Million) Table 86. North America Hidradenitis Suppurativa Treatment Market Size by Type (2027-2032) & (US$ Million) Table 87. North America Hidradenitis Suppurativa Treatment Market Size by Application (2021-2026) & (US$ Million) Table 88. North America Hidradenitis Suppurativa Treatment Market Size by Application (2027-2032) & (US$ Million) Table 89. North America Hidradenitis Suppurativa Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. North America Hidradenitis Suppurativa Treatment Market Size by Country (2021-2026) Table 91. North America Hidradenitis Suppurativa Treatment Market Size by Country (2027-2032) Table 92. Europe Hidradenitis Suppurativa Treatment Market Size by Type (2021-2026) & (US$ Million) Table 93. Europe Hidradenitis Suppurativa Treatment Market Size by Type (2027-2032) & (US$ Million) Table 94. Europe Hidradenitis Suppurativa Treatment Market Size by Application (2021-2026) & (US$ Million) Table 95. Europe Hidradenitis Suppurativa Treatment Market Size by Application (2027-2032) & (US$ Million) Table 96. Europe Hidradenitis Suppurativa Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. Europe Hidradenitis Suppurativa Treatment Market Size by Country (2021-2026) Table 98. Europe Hidradenitis Suppurativa Treatment Market Size by Country (2027-2032) Table 99. China Hidradenitis Suppurativa Treatment Market Size by Type (2021-2026) & (US$ Million) Table 100. China Hidradenitis Suppurativa Treatment Market Size by Type (2027-2032) & (US$ Million) Table 101. China Hidradenitis Suppurativa Treatment Market Size by Application (2021-2026) & (US$ Million) Table 102. China Hidradenitis Suppurativa Treatment Market Size by Application (2027-2032) & (US$ Million) Table 103. Asia Hidradenitis Suppurativa Treatment Market Size by Type (2021-2026) & (US$ Million) Table 104. Asia Hidradenitis Suppurativa Treatment Market Size by Type (2027-2032) & (US$ Million) Table 105. Asia Hidradenitis Suppurativa Treatment Market Size by Application (2021-2026) & (US$ Million) Table 106. Asia Hidradenitis Suppurativa Treatment Market Size by Application (2027-2032) & (US$ Million) Table 107. Asia Hidradenitis Suppurativa Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Asia Hidradenitis Suppurativa Treatment Market Size by Country (2021-2026) Table 109. Asia Hidradenitis Suppurativa Treatment Market Size by Country (2027-2032) Table 110. South America, Middle East & Africa Hidradenitis Suppurativa Treatment Market Size by Type (2021-2026) & (US$ Million) Table 111. South America, Middle East & Africa Hidradenitis Suppurativa Treatment Market Size by Type (2027-2032) & (US$ Million) Table 112. South America, Middle East & Africa Hidradenitis Suppurativa Treatment Market Size by Application (2021-2026) & (US$ Million) Table 113. South America, Middle East & Africa Hidradenitis Suppurativa Treatment Market Size by Application (2027-2032) & (US$ Million) Table 114. South America, Middle East & Africa Hidradenitis Suppurativa Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. South America, Middle East & Africa Hidradenitis Suppurativa Treatment Market Size by Country (2021-2026) Table 116. South America, Middle East & Africa Hidradenitis Suppurativa Treatment Market Size by Country (2027-2032) Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Hidradenitis Suppurativa Treatment Product Image Figure 2. Global Hidradenitis Suppurativa Treatment Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Hidradenitis Suppurativa Treatment Market Share by Type: 2025 VS 2032 Figure 4. Medications Image Figure 5. Surgery Image Figure 6. Others Image Figure 7. Global Hidradenitis Suppurativa Treatment Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Hidradenitis Suppurativa Treatment Market Share by Application: 2025 VS 2032 Figure 9. Hospitals Image Figure 10. Clinics Image Figure 11. Others Image Figure 12. Global Hidradenitis Suppurativa Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Hidradenitis Suppurativa Treatment Market Size (2021-2032) & (US$ Million) Figure 14. Global Hidradenitis Suppurativa Treatment Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Hidradenitis Suppurativa Treatment Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Hidradenitis Suppurativa Treatment Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Hidradenitis Suppurativa Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Hidradenitis Suppurativa Treatment Revenue Market Share by Type (2021-2032) Figure 21. Global Hidradenitis Suppurativa Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Hidradenitis Suppurativa Treatment Revenue Market Share by Application (2021-2032) Figure 23. North America Hidradenitis Suppurativa Treatment Market Size (2021-2032) & (US$ Million) Figure 24. North America Hidradenitis Suppurativa Treatment Market Share by Type (2021-2032) Figure 25. North America Hidradenitis Suppurativa Treatment Market Share by Application (2021-2032) Figure 26. North America Hidradenitis Suppurativa Treatment Market Share by Country (2021-2032) Figure 27. United States Hidradenitis Suppurativa Treatment Market Size (2021-2032) & (US$ Million) Figure 28. Canada Hidradenitis Suppurativa Treatment Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Hidradenitis Suppurativa Treatment Market Size (2021-2032) & (US$ Million) Figure 30. Europe Hidradenitis Suppurativa Treatment Market Size (2021-2032) & (US$ Million) Figure 31. Europe Hidradenitis Suppurativa Treatment Market Share by Type (2021-2032) Figure 32. Europe Hidradenitis Suppurativa Treatment Market Share by Application (2021-2032) Figure 33. Europe Hidradenitis Suppurativa Treatment Market Share by Country (2021-2032) Figure 34. Germany Hidradenitis Suppurativa Treatment Market Size (2021-2032) & (US$ Million) Figure 35. France Hidradenitis Suppurativa Treatment Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Hidradenitis Suppurativa Treatment Market Size (2021-2032) & (US$ Million) Figure 37. Italy Hidradenitis Suppurativa Treatment Market Size (2021-2032) & (US$ Million) Figure 38. Russia Hidradenitis Suppurativa Treatment Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Hidradenitis Suppurativa Treatment Market Size (2021-2032) & (US$ Million) Figure 40. China Hidradenitis Suppurativa Treatment Market Size (2021-2032) & (US$ Million) Figure 41. China Hidradenitis Suppurativa Treatment Market Share by Type (2021-2032) Figure 42. China Hidradenitis Suppurativa Treatment Market Share by Application (2021-2032) Figure 43. Asia Hidradenitis Suppurativa Treatment Market Size (2021-2032) & (US$ Million) Figure 44. Asia Hidradenitis Suppurativa Treatment Market Share by Type (2021-2032) Figure 45. Asia Hidradenitis Suppurativa Treatment Market Share by Application (2021-2032) Figure 46. Asia Hidradenitis Suppurativa Treatment Market Share by Country (2021-2032) Figure 47. Japan Hidradenitis Suppurativa Treatment Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Hidradenitis Suppurativa Treatment Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Hidradenitis Suppurativa Treatment Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Hidradenitis Suppurativa Treatment Market Size (2021-2032) & (US$ Million) Figure 51. India Hidradenitis Suppurativa Treatment Market Size (2021-2032) & (US$ Million) Figure 52. Australia Hidradenitis Suppurativa Treatment Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Hidradenitis Suppurativa Treatment Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Hidradenitis Suppurativa Treatment Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Hidradenitis Suppurativa Treatment Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Hidradenitis Suppurativa Treatment Market Share by Country (2021-2032) Figure 57. Brazil Hidradenitis Suppurativa Treatment Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Hidradenitis Suppurativa Treatment Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Hidradenitis Suppurativa Treatment Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Hidradenitis Suppurativa Treatment Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Hidradenitis Suppurativa Treatment Market Size (2021-2032) & (US$ Million) Figure 62. UAE Hidradenitis Suppurativa Treatment Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Hidradenitis Suppurativa Treatment Market Size (2021-2032) & (US$ Million) Figure 64. Chile Hidradenitis Suppurativa Treatment Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Medications
  • Surgery
  • Others
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • AbbVie
  • Merck
  • Pfizer
  • AstraZeneca
  • GlaxoSmithKline
  • Perrigo
  • Sun Pharma
  • Almirall
  • Bausch Health
  • Johnson & Johnson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Hidradenitis Suppurativa Treatment Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Medications
  5. 1.2.3 Surgery
  6. 1.2.4 Others
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Hidradenitis Suppurativa Treatment Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Hospitals
  10. 1.3.3 Clinics
  11. 1.3.4 Others
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Hidradenitis Suppurativa Treatment Growth Trends by Region
  14. 1.5.1 Global Hidradenitis Suppurativa Treatment Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Hidradenitis Suppurativa Treatment Market Size by Region (2021-2026)
  16. 1.5.3 Hidradenitis Suppurativa Treatment Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Hidradenitis Suppurativa Treatment Market Dynamics
  1. 2.1 Hidradenitis Suppurativa Treatment Industry Trends
  2. 2.2 Hidradenitis Suppurativa Treatment Industry Drivers
  3. 2.3 Hidradenitis Suppurativa Treatment Industry Opportunities and Challenges
  4. 2.4 Hidradenitis Suppurativa Treatment Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Hidradenitis Suppurativa Treatment Revenue by Company (2021-2026)
  2. 3.2 Global Hidradenitis Suppurativa Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Hidradenitis Suppurativa Treatment Key Company Head office and Area Served
  4. 3.4 Global Hidradenitis Suppurativa Treatment Company, Product Type & Application
  5. 3.5 Global Hidradenitis Suppurativa Treatment Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Hidradenitis Suppurativa Treatment Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Hidradenitis Suppurativa Treatment Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Hidradenitis Suppurativa Treatment Tier 1, Tier 2, and Tier 3
4 Hidradenitis Suppurativa Treatment Market by Type
  1. 4.1 Global Hidradenitis Suppurativa Treatment Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Hidradenitis Suppurativa Treatment Market Size by Type (2021-2032)
  3. 4.3 Global Hidradenitis Suppurativa Treatment Market Size Share by Type (2021-2032)
5 Hidradenitis Suppurativa Treatment Market by Application
  1. 5.1 Global Hidradenitis Suppurativa Treatment Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Hidradenitis Suppurativa Treatment Market Size by Application (2021-2032)
  3. 5.3 Global Hidradenitis Suppurativa Treatment Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 AbbVie
  2. 6.1.1 AbbVie Company Information
  3. 6.1.2 AbbVie Business Overview
  4. 6.1.3 AbbVie Hidradenitis Suppurativa Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 AbbVie Hidradenitis Suppurativa Treatment Product Portfolio
  6. 6.1.5 AbbVie Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck Hidradenitis Suppurativa Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Merck Hidradenitis Suppurativa Treatment Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Hidradenitis Suppurativa Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Pfizer Hidradenitis Suppurativa Treatment Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 AstraZeneca
  20. 6.4.1 AstraZeneca Company Information
  21. 6.4.2 AstraZeneca Business Overview
  22. 6.4.3 AstraZeneca Hidradenitis Suppurativa Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 AstraZeneca Hidradenitis Suppurativa Treatment Product Portfolio
  24. 6.4.5 AstraZeneca Recent Developments
  25. 6.5 GlaxoSmithKline
  26. 6.5.1 GlaxoSmithKline Company Information
  27. 6.5.2 GlaxoSmithKline Business Overview
  28. 6.5.3 GlaxoSmithKline Hidradenitis Suppurativa Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 GlaxoSmithKline Hidradenitis Suppurativa Treatment Product Portfolio
  30. 6.5.5 GlaxoSmithKline Recent Developments
  31. 6.6 Perrigo
  32. 6.6.1 Perrigo Company Information
  33. 6.6.2 Perrigo Business Overview
  34. 6.6.3 Perrigo Hidradenitis Suppurativa Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Perrigo Hidradenitis Suppurativa Treatment Product Portfolio
  36. 6.6.5 Perrigo Recent Developments
  37. 6.7 Sun Pharma
  38. 6.7.1 Sun Pharma Company Information
  39. 6.7.2 Sun Pharma Business Overview
  40. 6.7.3 Sun Pharma Hidradenitis Suppurativa Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Sun Pharma Hidradenitis Suppurativa Treatment Product Portfolio
  42. 6.7.5 Sun Pharma Recent Developments
  43. 6.8 Almirall
  44. 6.8.1 Almirall Company Information
  45. 6.8.2 Almirall Business Overview
  46. 6.8.3 Almirall Hidradenitis Suppurativa Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Almirall Hidradenitis Suppurativa Treatment Product Portfolio
  48. 6.8.5 Almirall Recent Developments
  49. 6.9 Bausch Health
  50. 6.9.1 Bausch Health Company Information
  51. 6.9.2 Bausch Health Business Overview
  52. 6.9.3 Bausch Health Hidradenitis Suppurativa Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Bausch Health Hidradenitis Suppurativa Treatment Product Portfolio
  54. 6.9.5 Bausch Health Recent Developments
  55. 6.10 Johnson & Johnson
  56. 6.10.1 Johnson & Johnson Company Information
  57. 6.10.2 Johnson & Johnson Business Overview
  58. 6.10.3 Johnson & Johnson Hidradenitis Suppurativa Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Johnson & Johnson Hidradenitis Suppurativa Treatment Product Portfolio
  60. 6.10.5 Johnson & Johnson Recent Developments
7 North America
  1. 7.1 North America Hidradenitis Suppurativa Treatment Market Size (2021-2032)
  2. 7.2 North America Hidradenitis Suppurativa Treatment Market Size by Type
  3. 7.2.1 North America Hidradenitis Suppurativa Treatment Market Size by Type (2021-2026)
  4. 7.2.2 North America Hidradenitis Suppurativa Treatment Market Size by Type (2027-2032)
  5. 7.2.3 North America Hidradenitis Suppurativa Treatment Market Share by Type (2021-2032)
  6. 7.3 North America Hidradenitis Suppurativa Treatment Market Size by Application
  7. 7.3.1 North America Hidradenitis Suppurativa Treatment Market Size by Application (2021-2026)
  8. 7.3.2 North America Hidradenitis Suppurativa Treatment Market Size by Application (2027-2032)
  9. 7.3.3 North America Hidradenitis Suppurativa Treatment Market Share by Application (2021-2032)
  10. 7.4 North America Hidradenitis Suppurativa Treatment Market Size by Country
  11. 7.4.1 North America Hidradenitis Suppurativa Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Hidradenitis Suppurativa Treatment Market Size by Country (2021-2026)
  13. 7.4.3 North America Hidradenitis Suppurativa Treatment Market Size by Country (2027-2032)
  14. 7.4.4 North America Hidradenitis Suppurativa Treatment Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Hidradenitis Suppurativa Treatment Market Size (2021-2032)
  2. 8.2 Europe Hidradenitis Suppurativa Treatment Market Size by Type
  3. 8.2.1 Europe Hidradenitis Suppurativa Treatment Market Size by Type (2021-2026)
  4. 8.2.2 Europe Hidradenitis Suppurativa Treatment Market Size by Type (2027-2032)
  5. 8.2.3 Europe Hidradenitis Suppurativa Treatment Market Share by Type (2021-2032)
  6. 8.3 Europe Hidradenitis Suppurativa Treatment Market Size by Application
  7. 8.3.1 Europe Hidradenitis Suppurativa Treatment Market Size by Application (2021-2026)
  8. 8.3.2 Europe Hidradenitis Suppurativa Treatment Market Size by Application (2027-2032)
  9. 8.3.3 Europe Hidradenitis Suppurativa Treatment Market Share by Application (2021-2032)
  10. 8.4 Europe Hidradenitis Suppurativa Treatment Market Size by Country
  11. 8.4.1 Europe Hidradenitis Suppurativa Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Hidradenitis Suppurativa Treatment Market Size by Country (2021-2026)
  13. 8.4.3 Europe Hidradenitis Suppurativa Treatment Market Size by Country (2027-2032)
  14. 8.4.4 Europe Hidradenitis Suppurativa Treatment Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Hidradenitis Suppurativa Treatment Market Size (2021-2032)
  2. 9.2 China Hidradenitis Suppurativa Treatment Market Size by Type
  3. 9.2.1 China Hidradenitis Suppurativa Treatment Market Size by Type (2021-2026)
  4. 9.2.2 China Hidradenitis Suppurativa Treatment Market Size by Type (2027-2032)
  5. 9.2.3 China Hidradenitis Suppurativa Treatment Market Share by Type (2021-2032)
  6. 9.3 China Hidradenitis Suppurativa Treatment Market Size by Application
  7. 9.3.1 China Hidradenitis Suppurativa Treatment Market Size by Application (2021-2026)
  8. 9.3.2 China Hidradenitis Suppurativa Treatment Market Size by Application (2027-2032)
  9. 9.3.3 China Hidradenitis Suppurativa Treatment Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Hidradenitis Suppurativa Treatment Market Size (2021-2032)
  2. 10.2 Asia Hidradenitis Suppurativa Treatment Market Size by Type
  3. 10.2.1 Asia Hidradenitis Suppurativa Treatment Market Size by Type (2021-2026)
  4. 10.2.2 Asia Hidradenitis Suppurativa Treatment Market Size by Type (2027-2032)
  5. 10.2.3 Asia Hidradenitis Suppurativa Treatment Market Share by Type (2021-2032)
  6. 10.3 Asia Hidradenitis Suppurativa Treatment Market Size by Application
  7. 10.3.1 Asia Hidradenitis Suppurativa Treatment Market Size by Application (2021-2026)
  8. 10.3.2 Asia Hidradenitis Suppurativa Treatment Market Size by Application (2027-2032)
  9. 10.3.3 Asia Hidradenitis Suppurativa Treatment Market Share by Application (2021-2032)
  10. 10.4 Asia Hidradenitis Suppurativa Treatment Market Size by Country
  11. 10.4.1 Asia Hidradenitis Suppurativa Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Hidradenitis Suppurativa Treatment Market Size by Country (2021-2026)
  13. 10.4.3 Asia Hidradenitis Suppurativa Treatment Market Size by Country (2027-2032)
  14. 10.4.4 Asia Hidradenitis Suppurativa Treatment Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Hidradenitis Suppurativa Treatment Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Hidradenitis Suppurativa Treatment Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Hidradenitis Suppurativa Treatment Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Hidradenitis Suppurativa Treatment Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Hidradenitis Suppurativa Treatment Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Hidradenitis Suppurativa Treatment Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Hidradenitis Suppurativa Treatment Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Hidradenitis Suppurativa Treatment Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Hidradenitis Suppurativa Treatment Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Hidradenitis Suppurativa Treatment Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Hidradenitis Suppurativa Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Hidradenitis Suppurativa Treatment Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Hidradenitis Suppurativa Treatment Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Hidradenitis Suppurativa Treatment Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst